Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 9Unknown 4Withdrawn 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Plasma cell 1Lymphoid 1Gastrointestinal 1

Conditions

Neoplasms 2Multiple Myeloma 1Lymphoma 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × darinaparsin × Clear all
NCT00423306 2013-11-14

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

Alaunos Therapeutics

Phase 2 Unknown
15 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00423644 2013-11-14

A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

Alaunos Therapeutics

Phase 2 Unknown
17 enrolled
Plasma cell

Multiple Myeloma

NCT00591422 2012-07-19

Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Alaunos Therapeutics

Phase 1 Unknown
23 enrolled
Tumor-Agnostic

Neoplasms

NCT00592163 2012-07-19

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Alaunos Therapeutics

Phase 1 Unknown
20 enrolled
Lymphoid

Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡